Yes, Hydroxychloroquine Can Damage the Eyes
Hydroxychloroquine (HCQ), used for malaria, lupus, and rheumatoid arthritis, carries a risk of retinal toxicity that can lead to irreversible vision loss. This affects the macula, causing blurred central vision, color changes, or blind spots. Damage is often permanent and progresses even after stopping the drug.[1][2]
How Common Is Retinal Toxicity?
Toxicity occurs in 7.5% of long-term users after 5+ years, rising to nearly 20% after 20 years. Early stages are asymptomatic, so routine screening is essential. Risk jumps with daily doses over 5 mg/kg of actual body weight or in patients with kidney disease, liver issues, or pre-existing retinal problems.[1][3]
What Does the Damage Look Like?
It starts with subtle parafoveal changes, progressing to a "bull's-eye" pattern of retinal pigment epithelium loss. Advanced cases involve photoreceptor damage, confirmed by tests like optical coherence tomography (OCT), fundus autofluorescence, or 10-2 visual fields. Unlike chloroquine, HCQ toxicity spares the central fovea initially, delaying detection.[2][4]
Who Is Most at Risk?
- Higher doses or duration: Toxicity is dose-dependent; guidelines cap HCQ at 5.0 mg/kg/day (real weight) for most adults, or 2.3 mg/kg for those under 50 kg or obese.[1]
- Pre-existing conditions: Tamoxifen use, renal failure, or macular disease multiplies risk 2-5 times.[3]
- Age and genetics: Older patients and those with specific genetic markers (e.g., certain EFEMP1 variants) face elevated odds.[4]
How Do Doctors Screen for It?
Annual exams are recommended after 5 years of use, including:
- Dilated fundus exam.
- 10-2 automated visual fields.
- Spectral-domain OCT or multifocal electroretinography (mfERG) for early detection.
Baseline screening before starting HCQ is standard. Stop the drug if toxicity is confirmed—reversibility is rare beyond early stages.[1][2]
Can Damage Be Reversed or Prevented?
Early detection via screening allows discontinuation, potentially halting progression, but most damage is irreversible. Prevention relies on weight-based dosing, regular monitoring, and avoiding high-risk combos. No proven treatments reverse advanced retinopathy.[3][4]
Hydroxychloroquine vs. Chloroquine Eye Risks
Chloroquine is more toxic (up to 40% risk after 20 years) with earlier foveal involvement. HCQ is safer overall but still requires vigilance—guidelines favor it for non-malaria uses.[1][2]
Sources
[1]: American Academy of Ophthalmology: Hydroxychloroquine and Chloroquine Retinopathy
[2]: New England Journal of Medicine: Hydroxychloroquine Retinopathy
[3]: AAO Focal Points: Hydroxychloroquine Retinopathy Screening
[4]: Ophthalmology: Risk Factors for HCQ Retinopathy